Identifying leukocyte gene expression patterns associated with plasma lipid levels in human subjects

Atherosclerosis

Volumn 191, Issue 1, 2007, Pages 63-72

  Ma, Jun ^a   Dempsey, Adam A ^a   Stamatiou, Dimitri ^a   Marshall, K Wayne ^a   Liew, Choong Chin ^a  

^a GeneNews Limited   (Canada)

Author keywords

Atherosclerosis; Coronary artery disease; Gene expression; Leukocyte; Lipid

Indexed keywords

HIGH DENSITY LIPOPROTEIN; LIPID; LOW DENSITY LIPOPROTEIN; TRANSCRIPTION FACTOR; TRIACYLGLYCEROL;

ADULT; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; FATTY ACID METABOLISM; FEMALE; GENE CONTROL; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE LOCATION; HUMAN; HUMAN CELL; HYPERLIPIDEMIA; IMMUNE RESPONSE; INFLAMMATION; LEUKOCYTE; LIPID ANALYSIS; LIPID BLOOD LEVEL; LIPID METABOLISM; LIPOGENESIS; MALE; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS; REGULATORY MECHANISM; RESPIRATORY CHAIN; RISK FACTOR; THROMBOCYTE ACTIVATION;

ADULT; ATHEROSCLEROSIS; BLOOD GLUCOSE; FATTY ACIDS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; LEUKOCYTES; LIPID METABOLISM; LIPIDS; MALE; MIDDLE AGED;

EID: 33846876581     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2006.05.032     Document Type: Article

References (34)

1. Murray C.J., and Lopez A.D. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 349 (1997) 1436-1442
2. Braunwald E. Shattuck lecture-cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. N Engl J Med 337 (1997) 1360-1369
3. Anderson K.M., Castelli W.P., and Levy D. Cholesterol and mortality. Thirty years of follow-up from the Framingham study. JAMA 257 (1987) 2176-2180
4. Martin M.J., Hulley S.B., Browner W.S., Kuller L.H., and Wentworth D. Serum cholesterol, blood pressure, and mortality: implications from a cohort of 361, 662 men. Lancet 2 (1986) 933-936
5. Cullen P. Evidence that triglycerides are an independent coronary heart disease risk factor. Am J Cardiol 86 (2000) 943-949
6. Young C.E., Karas R.H., and Kuvin J.T. High-density lipoprotein cholesterol and coronary heart disease. Cardiol Rev 12 (2004) 107-119
7. Assmann G., and Gotto Jr. A.M. HDL cholesterol and protective factors in atherosclerosis. Circulation 109 S1 (2004) III8-III14
8. Willerson J.T., and Ridker P.M. Inflammation as a cardiovascular risk factor. Circulation 109 S1 (2004) II2-II10
9. Libby P. Inflammation in atherosclerosis. Nature 420 (2002) 868-874
10. Libby P., Ridker P.M., and Maseri A. Inflammation and atherosclerosis. Circulation 105 (2002) 1135-1143
11. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 340 (1999) 115-126
12. Elkind M.S., Sciacca R., Boden-Albala B., Homma S., and Di Tullio M.R. Leukocyte count is associated with aortic arch plaque thickness. Stroke 33 (2002) 2587-2592
13. Huang Z.S., Jeng J.S., Wang C.H., Yip P.K., Wu T.H., and Lee T.K. Correlations between peripheral differential leukocyte counts and carotid atherosclerosis in non-smokers. Atherosclerosis 158 (2001) 431-436
14. Elkind M.S., Cheng J., Boden-Albala B., Paik M.C., and Sacco R.L. Northern Manhattan Stroke Study. Elevated white blood cell count and carotid plaque thickness: the northern Manhattan stroke study. Stroke 32 (2001) 842-849
15. Ikata J., Wakatsuki T., Oishi Y., Oki T., and Ito S. Leukocyte counts and concentrations of soluble adhesion molecules as predictors of coronary atherosclerosis. Coron Artery Dis 11 (2000) 445-449
16. Labarrere C.A., and Zaloga G.P. C-reactive protein: from innocent bystander to pivotal mediator of atherosclerosis. Am J Med 117 7 (2004) 499-507
17. Libby P., and Ridker P.M. Inflammation and atherosclerosis: role of C-reactive protein in risk assessment. Am J Med 116 Suppl. 6A (2004) 9S-16S
18. Calvano S.E., Xiao W., Richards D.R., et al. A network-based analysis of systemic inflammation in humans. Nature 437 7061 (2005) 1032-1037
19. Wettinger S.B., Doggen C.J., Spek C.A., Rosendaal F.R., and Reitsma P.H. High throughput mRNA profiling highlights associations between myocardial infarction and aberrant expression of inflammatory molecules in blood cells. Blood 105 5 (2005) 2000-2006
20. Van Oostrom A.J., Sijmonsma T.P., Rabelink T.J., Van Asbeck B.S., and Cabezas M.C. Postprandial leukocyte increase in healthy subjects. Metabolism 52 (2003) 199-202
21. Van Oostrom A.J., Sijmonsma T.P., Verseyden C., et al. Postprandial recruitment of neutrophils may contribute to endothelial dysfunction. J Lipid Res 44 (2003) 576-583
22. Van Oostrom A.J., Rabelink T.J., Verseyden C., et al. Activation of leukocytes by postprandial lipemia in healthy volunteers. Atherosclerosis 177 (2004) 175-182
23. Brazma A., Hingamp P., Quackenbush J., Sherlock G., et al. Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nature Genet 29 (2001) 365-371
24. Wu Z, LeBlanc R, Irizarry RA. Stochastic models based on molecular hybridization theory for short oligonucleotide microarrays technical report. Johns Hopkins University. Department of Biostatistics Working Papers; 2003.
25. Whitney A.R., Diehn M., Popper S.J., et al. Individuality and variation in gene expression patterns in human blood. Proc Natl Acad Sci USA 100 (2003) 1896-1901
26. Pandey R., Guru R.K., and Mount D.W. Pathway Miner: extracting gene association networks from molecular pathways for predicting the biological significance of gene expression microarray data. Bioinformatics 20 (2004) 2156-2158
27. Wang X., and Paigen B. Genetics of variation in HDL cholesterol in humans and mice. Circ Res 96 (2005) 27-42
28. Wang X., and Paigen B. Genome-wide search for new genes controlling plasma lipid concentrations in mice and humans. Curr Opin Lipidol 16 (2005) 127-137
29. Ma J., and Liew C.C. Gene profiling identifies secreted protein transcripts from peripheral blood cells in coronary artery disease. J Mol Cell Cardiol 35 (2003) 993-998
30. Morello F., de Bruin T.W.A., Rotter J.I., et al. Differential gene expression of blood-derived cell lines in familial combined hyperlipidemia. Arterioscler Thromb Vasc Biol 24 (2004) 2149-2154
31. Hubner N., Wallace C.A., Zimdahl H., et al. Integrated transcriptional profiling and linkage analysis for identification of genes underlying disease. Nat Genet 37 (2005) 243-253
32. Wahli W., Braissant O., and Desvergne B. Peroxisome proliferator activated receptors: transcriptional regulators of adipogenesis, lipid metabolism and more. Chem Biol 2 (1995) 261-266
33. Delerive P., Fruchart J.C., and Staels B. Peroxisome proliferator-activated receptors in inflammation control. J Endocrinol 169 (2001) 453-459
34. Elangbam C.S., Tyler R.D., and Lightfoot R.M. Peroxisome proliferator-activated receptors in atherosclerosis and inflammation-an update. Toxicol Pathol 29 (2001) 224-231